These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 16533506

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K, Hatori Y, Murayama T, Tashima K, Wongseripipatana S, Misawa K, Kitajima M, Takayama H, Horie S.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):63-70. PubMed ID: 16978601
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice.
    Kamei J, Kawashima N, Iwamoto Y, Suzuki T, Nagase H, Misawa M, Kasuya Y.
    Psychopharmacology (Berl); 1993 Nov 07; 113(2):167-71. PubMed ID: 7855177
    [Abstract] [Full Text] [Related]

  • 28. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M, Mizoguchi H, Narita M, Chu M, Nagase H, Tseng LF.
    J Pharmacol Exp Ther; 2000 Sep 07; 294(3):1106-11. PubMed ID: 10945866
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
    Narita M, Imai S, Itou Y, Yajima Y, Suzuki T.
    Life Sci; 2002 Apr 05; 70(20):2341-54. PubMed ID: 12150199
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Agonist and antagonist properties of dihydroetorphine for mu-opioid receptors in mice.
    Kamei J, Suzuki T, Nagase H.
    Neurosci Lett; 1996 Sep 06; 215(2):87-90. PubMed ID: 8888002
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice.
    Kamei J, Saitoh A, Ohsawa M, Suzuki T, Misawa M, Nagase H, Kasuya Y.
    Eur J Pharmacol; 1995 Mar 24; 276(1-2):131-5. PubMed ID: 7781682
    [Abstract] [Full Text] [Related]

  • 36. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
    Bhalla S, Zhang Z, Patterson N, Gulati A.
    Eur J Pharmacol; 2010 Jun 10; 635(1-3):62-71. PubMed ID: 20303944
    [Abstract] [Full Text] [Related]

  • 37. The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
    Kamei J, Kashiwazaki T, Hitosugi H, Nagase H.
    Eur J Pharmacol; 1997 May 12; 326(1):31-6. PubMed ID: 9178652
    [Abstract] [Full Text] [Related]

  • 38. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF, Narita M, Mizoguchi H, Kawai K, Mizusuna A, Kamei J, Suzuki T, Nagase H.
    J Pharmacol Exp Ther; 1997 Feb 12; 280(2):600-5. PubMed ID: 9023269
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.